Hewlett-Packard (NYSE: HPQ ) shares soared sky-high on Thursday thanks to a surprisingly solid second-quarter report. On Friday, HP threw its engines into reverse. The strongest Dow Jones (DJINDICES: ^DJI ) component one day became the weakest of the next day.
Fellow Fool Dan Caplinger posits that HP's 2.5% drop is nothing but a pullback after Thursday's 17% dose of enthusiasm. That's certainly part of the picture, but I think there's more to this steep reversal.
I'm not convinced that HP's recent success is sustainable, and HP investors are slowly waking up to this uncomfortable idea. It's not a bucket of ice water to the face, but rather more of a sluggish, queasy morning after the earnings-induced party.
CEO Meg Whitman remains committed to HP's current strategy. This means keeping the company intact, rather than splitting it into two nimbler companies, while firing diluted blunderbuss shots at every market in sight. Separating into a consumer company and a business-class company would help each division double down on the opportunities that truly matter while dropping unprofitable lead weights as appropriate.
Top 5 Chemical Companies To Own In Right Now: IRSA Inversiones Y Representaciones S.A. (IRS)
IRSA Investments and Representations Inc., through its subsidiaries, engages in a range of diversified real estate investment and related activities in Argentina. The company is involved in the acquisition, development, and operation of shopping centers, offices, and other non-shopping center properties primarily for rental purposes; development and sale of residential properties; acquisition and operation of luxury hotels; and acquisition of undeveloped land reserves for future development purpose. It also engages in consumer financing activities, including credit card products to its consumers at shopping centers, hypermarkets, and street stores. IRSA Investments and Representations, Inc. was founded in 1943 and is headquartered in Buenos Aires, Argentina.
Advisors' Opinion:- [By Garrett Cook]
In trading on Wednesday, financial shares were relative laggards, down on the day by about 0.24 percent. Top losers in the sector included IRSA Investments and Representations (NYSE: IRS), down 3.2 percent, and OceanFirst Financial (NASDAQ: OCFC), off 2.5 percent.
Top 5 High Tech Companies To Buy For 2014: Universal Stainless & Alloy Products Inc (USAP)
Universal Stainless & Alloy Products, Inc., incorporated in 1994, manufactures and markets semi-finished and finished specialty steel products, including stainless steel, tool steel and certain other alloyed steels. The Company�� manufacturing process involves melting, re-melting, heat treating, hot and cold rolling, forging, machining and cold drawing of semi-finished and finished specialty steels. The Company�� products are sold to re-rollers, forgers, service centers, original equipment manufacturers (OEMs) and wire re-drawers. The Company�� customers further process its products for use in a range of industries, including the aerospace, power generation, petrochemical and heavy equipment manufacturing industries. The Company also performs conversion services on materials supplied by customers, which lack certain of the Company�� production facilities or that are subject to their own capacity constraints. On August 18, 2011, the Company acquired Patriot Special Metals, Inc. and RSM Real Estate Holding, Inc.
The Company operates in two segments: Universal Stainless & Alloy Products (USAP) and Dunkirk Specialty Steel. The Company�� products are manufactured in a range of grades and melt qualities, including argon oxygen decarburization (AOD) quality, electro-slag remelted (ESR) quality, vacuum induction melting (VIM) quality and vacuum-arc remelted (VAR) quality. At its Bridgeville facility, the Company produces specialty steel products in the form of long products (ingots, blooms, billets and bars) and flat rolled products (slabs and plates). In December 2011, the Company began melting in its new VIM furnace located in North Jackson. The semi-finished long products are used by the Company�� Dunkirk facility and certain customers to produce finished bar, rod and wire products, and the semi-finished flat rolled products are used by customers to produce light-gauge plate, sheet and strip products. The finished bar products manufactured by the Company are used by OEMs and by ser! vice center customers for distribution to a range of end users. The Company also produces customized shapes for OEMs that are cold rolled from purchased coiled strip, flat bar or extruded bar at its Precision Rolled Products department, located at its Titusville facility.
Advisors' Opinion:- [By Jake L'Ecuyer]
In trading on Wednesday, basic materials shares dropped by 0.30 percent. Among the sector stocks, Amyris (NASDAQ: AMRS) was down more than 8.5 percent, while Universal Stainless & Alloy Products (NASDAQ: USAP) tumbled around 5 percent.
- [By Seth Jayson]
Universal Stainless & Alloy Products (Nasdaq: USAP ) reported earnings on May 1. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Universal Stainless & Alloy Products missed estimates on revenues and missed estimates on earnings per share. - [By Jake L'Ecuyer]
In trading on Wednesday, basic materials shares dropped by 0.30 percent. Among the sector stocks,Amyris (NASDAQ: AMRS) was down more than 8.5 percent, while Universal Stainless & Alloy Products (NASDAQ: USAP) tumbled around 5 percent.
Top 5 High Tech Companies To Buy For 2014: Thomson Reuters Corp(TRI)
Thomson Reuters Corporation provides intelligent information for businesses and professionals worldwide. The company allows market participants to connect, access content, and trade in a secure environment through Thomson Reuters Eikon desktop, Thomson Reuters Elektron network, content integration and management technology, content feeds and databases, and transactions infrastructure solutions that support buy- and sell-side customers to trade in foreign exchange, fixed income and derivatives, equities, exchange-traded instruments, and commodities and energy markets. It also offers information, analytics, workflow, and technology solutions to buy-side and off-trading floor customers; access to liquidity in over-the-counter markets, trade execution, and connections for market participants and financial professionals? communities; and a suite of solutions offering informed outcomes to regulated industries and law firms. In addition, the company provides critical information , decision support tools, and software and services to legal, investigation, business, and government professionals; integrated tax compliance and accounting software and services for accounting and law firms, corporations, and government professionals; intellectual property and scientific resources that enable its customers to discover, develop, and deliver innovations; and data analytics, and performance benchmarking solutions and services to healthcare sector. Further, it offers coverage of global, regional, and national news in 20 languages covering politics, business, finance, entertainment, lifestyle, technology, health, science, and sports; and engages in advertising-supported direct-to-consumer publishing activities of Reuters.com and its network of Websites, mobile applications, and electronic out-of-home displays. The company was formerly known as The Thomson Corporation and changed its name to Thomson Reuters Corporation in April 2008. The company is headquartered in New York, New York.
Advisors' Opinion:- [By Jonas Elmerraji]
It's been a solid year for Thompson Reuters (TRI); since the calendar flipped over to January, this $30 billion financial media firm has rallied more than 22%. But don't worry if you've missed out on the move -- TRI looks well-positioned for higher levels thanks to the pattern that's been setting up in shares.
Thompson Reuters is currently forming an ascending triangle pattern, a bullish setup that's formed by horizontal resistance above shares at the $35.50 level and uptrending support to the downside. Basically, as TRI bounces in between those two technically-important price levels, it's getting squeezed closer and closer to a confirmed breakout above that $35.50 price level. When the breakout happens, it's time to be a buyer.
TRI closed above the $35.50 level in yesterday's session, but it's a little early to call it a breakout just yet. If shares can hold above that breakout level all through today's session, then the buy signal is worth heeding.
- [By Rich Smith]
Thomson Reuters (NYSE: TRI ) has acquired Canadian trademark search, monitoring, and screening firm Onscope, Thomson announced Tuesday.
Top 5 High Tech Companies To Buy For 2014: Imprimis Pharmaceuticals Inc (IMMY)
Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company�� Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company�� lead pain product, utilizes the Transdel platform technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its anti-inflammatory and analgesic effects. Ketotransdel consists of a transdermal formulation of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its Transdel drug delivery system and is being developed for the treatment of acute pain. In July 2013, it acquired intellectual property for IPI-120 from Buderer Drug Company.
Ketotransdel penetrates the skin barrier to reach the targeted underlying tissues where it exerts its localized anti-inflammatory and analgesic effect. Transdel is the Company�� transdermal cream drug delivery platform. It consists of a cream that enables transdermal penetration of drugs avoiding first pass metabolism by the liver and minimizing systemic exposure. The Transdel drug delivery system facilitates the effective dissolution and delivery of a drug across the skin barrier to reach targeted underlying tissues.
Advisors' Opinion:- [By John Udovich]
So far this year, Rexahn Pharmaceuticals, Inc (NYSEMKT: RNN), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and Arrowhead Research Corp (NASDAQ: ARWR) are up 186.3%, 157.2% and 142.5%, respectively, since the start of the year���making them the best performing small cap biotech stocks for 2014. But given their lackluster performance over the past few years, what is the secret behind their phenomenal 2014 rise and will they keep rising? For starters, none of these small caps have really produced anything in the way of blockbuster news:
- [By John Udovich]
The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:
No comments:
Post a Comment